PROXIMAGEN NEUROSCIENCE PLC ("Proximagen" or "the Company") Notification of Preliminary Results for the twelve months ended 30 November 2006 London, UK, 16 February 2007 Proximagen Neuroscience plc (AIM: PRX), the specialty drug discovery and development company focused on neurodegenerative diseases, will announce its Preliminary Results for the twelve months ended 30 November 2006 on Wednesday 28 February 2007. An analyst meeting will be held at 09:00am on 28 February at the offices of Buchanan Communications, 45 Moorfields, London EC2Y 9AE.
For more information please contact:
|